In vitro fertilisation treatment and factors affecting success

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 26, Issue 6, 2012, Pages 777-788

  Huang, Jack Yu Jen ^a   Rosenwaks, Zev ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

anti Mullerian hormone (AMH); assisted reproductive technology (ART); controlled ovarian hyperstimulation (COH); embryo transfer; follicle stimulating hormone (FSH); in vitro fertilization (IVF); intracytoplasmic sperm injection (ICSI); ovarian hyperstimulation syndrome (OHSS); ovarian reserve

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; GONADORELIN AGONIST; GONADOTROPIN;

ARTICLE; CONCEPTION; ENDOMETRIOSIS; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; MATERNAL AGE; METABOLOMICS; OVARY HYPERSTIMULATION; OVULATION; PRIORITY JOURNAL; PROTEOMICS; TRANSCRIPTOMICS;

EID: 84867870538     PISSN: 15216934     EISSN: 15321932     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2012.08.017     Document Type: Review

References (108)

1. P.C. Steptoe, and R.G. Edwards Reimplantation of a human embryo with subsequent tubal pregnancy Lancet 307 1976 880 882
2. P.C. Steptoe, and R.G. Edwards Birth after reimplantation of a human embryo Lancet 312 1978 366
3. Centers for disease control and prevention 2008 assisted reproductive technology success rates: national summary and fertility clinic reports 2011 [last accessed10.08.12] http://www.cdc.gov/art/ART2008/index.htm
4. J. de Mouzon, V. Goossens, and S. Bhattacharya Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE Hum Reprod 25 2010 1851 1862
5. K.G. Nygren, E. Sullivan, and F. Zegers-Hochschild International Committee for Monitoring Assisted Reproductive Technology (ICMART) world report: assisted reproductive technology 2003 Fertil Steril 95 2011 2209-22.e1-17
6. ESHRE Guidelines and Legal. ART fact sheet. 2010; http://www.eshre.eu/ ESHRE/English/Guidelines-Legal/ART-fact-sheet/page.aspx/1061 [last accessed 10.08.12].
7. G. Palermo, H. Joris, and P. Devroey Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte Lancet 340 1992 17 28
8. C.A. Benadiva, I. Kligman, and O. Davis In vitro fertilization versus tubal surgery: is pelvic reconstructive surgery obsolete? Fertil Steril 64 1995 1051 1061
9. Practice Committee of American Society for Reproductive Medicine The role of tubal reconstructive surgery in the era of assisted reproductive technologies Fertil Steril 90 Suppl. 1 2008 S250 S253
10. P. Thonneau, S. Marchand, and A. Tallec Incidence and main causes of infertility in a resident population (1,850,000) of three French regions (1988-1989) Hum Reprod 6 1991 811 816
11. A.I. Vawda, J. Gunby, and E.V. Younglai Andrology: semen parameters as predictors of in-vitro fertilization: the importance of strict criteria sperm morphology Hum Reprod 11 1996 1445 1450
12. A. Campana, D. Sakkas, and A. Stalberg Intrauterine insemination: evaluation of the results according to the woman's age, sperm quality, total sperm count per insemination and life table analysis Hum Reprod 11 1996 732 736
13. B.J. Van Voorhis, M. Barnett, and A.E.T. Sparks Effect of the total motile sperm count on the efficacy and cost-effectiveness of intrauterine insemination and in vitro fertilization Fertil Steril 75 2001 661 668
14. P. Devroey, J. Liu, and Z. Nagy Normal fertilization of human oocytes after testicular sperm extraction and intracytoplasmic sperm injection Fertil Steril 62 1994 639 641
15. P. Devroey, J. Liu, and Z. Nagy Pregnancies after testicular sperm extraction and intracytoplasmic sperm injection in non-obstructive azoospermia Hum Reprod 10 1995 1457 1460
16. P.N. Schlegel, G.D. Palermo, and M. Goldstein Testicular sperm extraction with intracytoplasmic sperm injection for nonobstructive azoospermia Urology 49 1997 435 440
17. S.A. Missmer, S.E. Hankinson, and D. Spiegelman Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors Am J Epidemiol 160 2004 784 796
18. J.H. Strathy, C.A. Molgaard, and C.B. Coulam Endometriosis and infertility: a laparoscopic study of endometriosis among fertile and infertile women Fertil Steril 38 1982 667 672
19. International Committee for Monitoring Assisted Reproductive Technology J. de Mouzon, P. Lancaster, and K.G. Nygren World collaborative report on assisted reproductive technology, 2002 Hum Reprod 24 2009 2310 2320
20. M. Toya, H. Saito, and N. Ohta Moderate and severe endometriosis is associated with alterations in the cell cycle of granulosa cells in patients undergoing in vitro fertilization and embryo transfer Fertil Steril 73 2000 344 350
21. G.D. Adamson, and D.J. Pasta Surgical treatment of endometriosis- associated infertility: meta-analysis compared with survival analysis Am J Obstet Gynecol 171 1994 1488 1504
22. S. Kennedy, A. Bergqvist, and C. Chapron ESHRE guideline for the diagnosis and treatment of endometriosis Hum Reprod 20 2005 2698 2704
23. E.S. Surrey, K.M. Silverberg, and M.W. Surrey Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis Fertil Steril 78 2002 699 704
24. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 19 2004 41 47
25. R.B. Greenblatt Chemical induction of ovulation Fertil Steril 12 1961 402 404
26. H. Holzer, R. Casper, and T. Tulandi A new era in ovulation induction Fertil Steril 85 2006 277 284
27. I.E. Messinis, and S.J. Nillius Comparison between tamoxifen and clomiphene for induction of ovulation Acta Obstet Gynecol Scand 61 1982 377 379
28. M.J. MacDougall, S.L. Tan, and H.S. Jacobs In vitro fertilization and the ovarian hyperstimulation syndrome Hum Reprod 7 1992 597 600
29. R. Agrawal, S.L. Tan, and S. Wild Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome Fertil Steril 71 1999 287 293
30. J. Nisker, I. Tummon, and S. Daniel Conversion of cycles involving ovarian hyperstimulation with intra-uterine insemination to in-vitro fertilization Hum Reprod 9 1994 406 408
31. J. Ashkenazi, D. Feldberg, and D. Dicker IVF-ET in women with refractory polycystic ovarian disease Eur J Obstet Gynecol Reprod Biol 30 1989 157 161
32. A.A. Templeton, and G.C. Penney The incidence, characteristics, and prognosis of patients whose infertility is unexplained Fertil Steril 37 1982 175 182
33. D.S. Guzick, I. Grefenstette, and K. Baffone Infertility: infertility evaluation in fertile women: a model for assessing the efficacy of infertility testing Hum Reprod 9 1994 2306 2310
34. R.H. Reindollar, M.M. Regan, and P.J. Neumann A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial Fertil Steril 94 2010 888 899
35. President's Cancer Panel 2003-2004 Annual Report Living beyond cancer: finding a new balance 2004 US Department of Health and Human Services Washington p. 1-87
36. S.E. Elizur, R.C. Chian, and C.A. Pineau Fertility preservation treatment for young women with autoimmune diseases facing treatment with gonadotoxic agents Rheumatology 47 2008 1506 1509
37. N.M. Lau, J.Y. Huang, and S. MacDonald Feasibility of fertility preservation in young females with Turner syndrome Reprod Biomed Online 18 2009 290 295
38. S.J. Lee, L.R. Schover, and A.H. Partridge American Society of Clinical Oncology recommendations on fertility preservation in cancer patients J Clin Oncol 24 2006 2917 2931
39. Ethics Committee of the American Society for Reproductive Medicine Fertility preservation and reproduction in cancer patients Fertil Steril 83 2005 1622 1628
40. N. Noyes, J.M. Knopman, and K. Melzer Oocyte cryopreservation as a fertility preservation measure for cancer patients Reprod Biomed Online 23 2011 323 333
41. J.Y.J. Huang, R.-C. Chian, and L. Gilbert Retrieval of immature oocytes from unstimulated ovaries followed by in vitro maturation and vitrification: a novel strategy of fertility preservation for breast cancer patients Am J Surg 200 2010 177 183
42. J. Donnez, S. Silber, and C.Y. Andersen Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births Ann Med 43 2011 437 450
43. K. Xu, Z.M. Shi, and L.L. Veeck First unaffected pregnancy using preimplantation genetic diagnosis for sickle cell anemia JAMA 281 1999 1701 1706
44. J.L. Simpson Preimplantation genetic diagnosis at 20 years Prenat Diag 30 2010 682 695
45. T.T. Cameron, F.C. O'Shea, and J.M. Rolland Occult ovarian failure: a syndrome of infertility, regular menses, and elevated follicle-stimulating hormone concentrations J Clin Endocrinol Metab 67 1988 1190 1194
46. J.P. Toner, C.B. Philput, and G.S. Jones Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age Fertil Steril 55 1991 784 791
47. D.B. Smotrich, E.A. Widra, and P.R. Gindoff Prognostic value of day 3 estradiol on in vitro fertilization outcome Fertil Steril 64 1995 1136 1140
48. F.L. Licciardi, H.C. Liu, and Z. Rosenwaks Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization Fertil Steril 64 1995 991 994
49. F.J. Broekmans, J. Kwee, and D.J. Hendriks A systematic review of tests predicting ovarian reserve and IVF outcome Hum Reprod Update 12 2006 685 718
50. S.L. Broer, B.W. Mol, and D. Hendriks The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count Fertil Steril 91 2009 705 711
51. S.M. Nelson, R.W. Yates, and H.J. Lyall Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception Hum Reprod 24 2009 867 875
52. C. Tomas, S. Nuojua-Huttunen, and H. Martikainen Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization Hum Reprod 12 1997 220 223
53. D. Navot, Z. Rosenwaks, and E.J. Margalioth Prognostic assessment of female fecundity Lancet 2 1987 645 647
54. R. Fanchin, D. de Ziegler, and F. Olivennes Endocrinology: exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting 'poor responders' in in-vitro fertilization Hum Reprod 9 1994 1607 1611
55. K.L. Winslow, J.P. Toner, and R.G. Brzyski The gonadotropin-releasing hormone agonist stimulation test - a sensitive predictor of performance in the flare-up in vitro fertilization cycle Fertil Steril 56 1991 711 717
56. A. Maheshwari, A. Gibreel, and S. Bhattacharya Dynamic tests of ovarian reserve: a systematic review of diagnostic accuracy Reprod Biomed Online 18 2009 717 734
57. S.L. Broer, M. Dólleman, and B.C. Opmeer AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis Hum Reprod Update 17 2011 46 54
58. R. Fanchin, J. Taieb, and D.H.M. Lozano High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status Hum Reprod 20 2005 923 927
59. K. Jayaprakasan, B. Campbell, and J. Hopkisson A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation Fertil Steril 93 2010 855 864
60. L.L. van Loendersloot, M. van Wely, and J. Limpens Predictive factors in in vitro fertilization (IVF): a systematic review and meta-analysis Hum Reprod Update 16 2010 577 589
61. R.L. Barbieri, and M.D. Hornstein Assisted reproduction-in vitro fertilization success is improved by ovarian stimulation with exogenous gonadotropins and pituitary suppression with gonadotropin-releasing hormone analogues Endocrine Rev 20 1999 249 252
62. P. Devroey, M. Aboulghar, and J. Garcia-Velasco Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment Hum Reprod 24 2009 764 774
63. M.J. MacDougall, S.L. Tan, and A. Balen A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization Hum Reprod 8 1993 233 237
64. L. Engmann, N. Maconochie, and P. Sladkevicius The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology Hum Reprod 14 1999 167 171
65. D. Navot, P.A. Bergh, and N. Laufer Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment Fertil Steril 58 1992 249 261
66. A. Enskog, M. Henriksson, and M. Unander Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization Fertil Steril 71 1999 808 814
67. J.G. Whelan, and N.F. Vlahos The ovarian hyperstimulation syndrome Fertil Steril 73 2000 883 896
68. J.Y.J. Huang, and Z. Rosenwaks Preventive strategies of ovarian hyperstimulation syndrome J Exp Clin Med 2 2010 53 62
69. M.A. Damario, L. Barmat, and H.C. Liu Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients Hum Reprod 12 1997 2359 2365
70. R.E. Felberbaum, T. Reissmann, and W. Küpker Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility Euro J Obstet Gynecol Reprod Biol 61 1995 151 155
71. J. Itskovitz-Eldor, S. Kol, and B. Mannaerts Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communication Hum Reprod 15 2000 1965 1968
72. The European Recombinant LHSG Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study J Clin Endocrinol Metab 86 2001 2607 2818
73. ®) in controlled ovarian stimulation for assisted reproduction Arch Gynecol Obstet 264 2000 29 32
74. S.D. Keay, N.H. Liversedge, and R.S. Mathur Assisted conception following poor ovarian response to gonadotrophin stimulation Br J Obstet Gynaecol 104 1997 521 527
75. V. Karande, R. Morris, and J. Rinehart Limited success using the 'flare' protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization Fertil Steril 67 1997 900 903
76. K. Droesch, S.J. Muasher, and R.G. Brzyski Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization Fertil Steril 51 1989 292 297
77. D. Feldberg, J. Farhi, and J. Ashkenazi Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels Fertil Steril 62 1994 343 346
78. B.M. Faber, J. Mayer, and B. Cox Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders Fertil Steril 69 1998 826 830
79. T.L. Toth, J.T. Awwad, and L.L. Veeck Suppression and flare regimens of gonadotropin-releasing hormone agonist. Use in women with different basal gonadotropin values in an in vitro fertilization program J Reprod Med 41 1996 321 326
80. A.G. Shaker, R. Fleming, and M.E. Jamieson Absence of effect of adjuvant growth hormone therapy on follicular responses to exogenous gonadotropins in women: normal and poor responders Fertil Steril 58 1992 919 923
81. E.S. Surrey, J. Bower, and D.M. Hill Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization Fertil Steril 69 1998 419 424
82. A.P. Ferraretti, A. La Marca, and B.C.J.M. Fauser ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria Hum Reprod 26 2011 1616 1624
83. M.J. Faddy, R.G. Gosden, and A. Gougeon Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause Hum Reprod 7 1992 1342 1346
84. B.A. Malizia, M.R. Hacker, and A.S. Penzias Cumulative live-birth rates after in vitro fertilization N Engl J Med 360 2009 236 243
85. S. Ziebe, A. Loft, and J.H. Petersen Embryo quality and developmental potential is compromised by age Acta Obstet Gynecol Scand 80 2001 169 174
86. M.G. Hull, C.F. Fleming, and A.O. Hughes The age-related decline in female fecundity: a quantitative controlled study of implanting capacity and survival of individual embryos after in vitro fertilization Fertil Steril 65 1996 783 790
87. S.D. Spandorfer, P.H. Chung, and I. Kligman An analysis of the effect of age on implantation rates J Assist Reprod Genet 17 2000 303 306
88. T. Hassold, and D. Chiu Maternal age-specific rates of numerical chromosome abnormalities with special reference to trisomy Hum Genet 70 1985 11 17
89. A.-M.N. Andersen, J. Wohlfahrt, and P. Christens Maternal age and fetal loss: population based register linkage study BMJ 320 2000 1708 1712
90. K.G. Dragisic, O.K. Davis, and S.J. Fasouliotis Use of a luteal estradiol patch and a gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation for in vitro fertilization in poor responders Fertil Steril 84 2005 1023 1026
91. J. Garcia, S. Padilla, and J. Bargati Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for in vitro fertilization Fertil Steril 53 1990 302 305
92. R. Scott, and D. Navot Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization Fertil Steril 61 1994 880 885
93. D. Manzi, K. Thorton, and L. Scott The value of increasing the dose of human menopausal gonadotropins in women who initially demonstrate a poor response Fertil Steril 62 1994 251 256
94. G. D'Amato, E. Caroppo, and A. Pasquadibisceglie A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years Fertil Steril 81 2004 1572 1577
95. W.B. Schoolcraft, E.S. Surrey, and D.A. Minjarez Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol? Fertil Steril 89 2008 151 156
96. V. Jovanovic, D. Kort, and M. Guarnaccia Does the addition of clomiphene citrate or letrazole to gonadotropin treatment enhance the oocyte yield in poor responders undergoing IVF? J Assist Reprod Genet 28 2011 1067 1072
97. M.J. Pelinck, N.E.A. Vogel, and A. Hoek Minimal stimulation IVF with late follicular phase administration of the GnRH antagonist cetrorelix and concomitant substitution with recombinant FSH: a pilot study Hum Reprod 20 2005 642 648
98. Z. Pandian, A.R. McTavish, and L. Aucott Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF) Cochrane Database Syst Rev 20 2010 CD004379
99. S. Assou, D. Haouzi, and J. De Vos Human cumulus cells as biomarkers for embryo and pregnancy outcomes Mol Hum Reprod 16 2010 531 538
100. M.G. Katz-Jaffe, S. McReynolds, and D.K. Gardner The role of proteomics in defining the human embryonic secretome Mol Hum Reprod 15 2009 271 277
101. M.G. Katz-Jaffe, W.B. Schoolcraft, and D.K. Gardner Analysis of protein expression (secretome) by human and mouse preimplantation embryos Fertil Steril 86 2006 678 685
102. D.R. Brison, F.D. Houghton, and D. Falconer Identification of viable embryos in IVF by non-invasive measurement of amino acid turnover Hum Reprod 19 2004 2319 2324
103. Z.P. Nagy, D. Sakkas, and B. Behr Symposium: innovative techniques in human embryo viability assessment. Non-invasive assessment of embryo viability by metabolomic profiling of culture media ('metabolomics') Reprod Biomed Online 17 2008 502 507
104. E. Seli, D. Sakkas, and R. Scott Noninvasive metabolomic profiling of embryo culture media using Raman and near-infrared spectroscopy correlates with reproductive potential of embryos in women undergoing in vitro fertilization Fertil Steril 88 2007 1350 1357
105. R. Scott, E. Seli, and K. Miller Noninvasive metabolomic profiling of human embryo culture media using Raman spectroscopy predicts embryonic reproductive potential: a prospective blinded pilot study Fertil Steril 90 2008 77 83
106. E. Seli, C.G. Vergouw, and H. Morita Noninvasive metabolomic profiling as an adjunct to morphology for noninvasive embryo assessment in women undergoing single embryo transfer Fertility and Sterility 94 2010 535 542
107. T. Hardarson, A. Ahlström, and L. Rogberg Non-invasive metabolomic profiling of day 2 and 5 embryo culture medium: a prospective randomized trial Hum Reprod 27 2012 89 96
108. C.C. Wong, K.E. Loewke, and N.L. Bossert Non-invasive imaging of human embryos before embryonic genome activation predicts development to the blastocyst stage Nat Biotech 28 2010 1115 1121